- Home
- STRO vs SRTS Comparison
STRO vs SRTS Comparison
Compare STRO & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- SRTS
- Stock Information
- Founded
- STRO 2003
- SRTS 2010
- Country
- STRO United States
- SRTS United States
- Employees
- STRO N/A
- SRTS N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- SRTS Medical/Dental Instruments
- Sector
- STRO Health Care
- SRTS Health Care
- Exchange
- STRO Nasdaq
- SRTS Nasdaq
- Market Cap
- STRO 77.7M
- SRTS 75.5M
- IPO Year
- STRO 2018
- SRTS 2016
- Fundamental
- Price
- STRO $0.88
- SRTS $5.29
- Analyst Decision
- STRO Hold
- SRTS Strong Buy
- Analyst Count
- STRO 7
- SRTS 3
- Target Price
- STRO $3.97
- SRTS $11.67
- AVG Volume (30 Days)
- STRO 513.9K
- SRTS 104.0K
- Earning Date
- STRO 08-12-2025
- SRTS 08-07-2025
- Dividend Yield
- STRO N/A
- SRTS N/A
- EPS Growth
- STRO N/A
- SRTS N/A
- EPS
- STRO N/A
- SRTS 0.11
- Revenue
- STRO $66,434,000.00
- SRTS $39,488,000.00
- Revenue This Year
- STRO N/A
- SRTS $4.33
- Revenue Next Year
- STRO N/A
- SRTS $26.74
- P/E Ratio
- STRO N/A
- SRTS $47.31
- Revenue Growth
- STRO N/A
- SRTS 24.75
- 52 Week Low
- STRO $0.52
- SRTS $4.01
- 52 Week High
- STRO $5.17
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- STRO 57.66
- SRTS 61.30
- Support Level
- STRO $0.83
- SRTS $5.21
- Resistance Level
- STRO $1.01
- SRTS $5.60
- Average True Range (ATR)
- STRO 0.07
- SRTS 0.34
- MACD
- STRO 0.01
- SRTS 0.11
- Stochastic Oscillator
- STRO 51.67
- SRTS 64.41
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.